These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4632089)

  • 1. Cardiac allograft pathology in Rhesus monkeys.
    Hollander CF
    Am J Phys Anthropol; 1973 Mar; 38(2):431-3. PubMed ID: 4632089
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of rejection of transplanted organs.
    Keown PA; Stiller CR
    Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of new immunosuppressant and experimental cardiac transplantation].
    Ochiai T
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1961-8. PubMed ID: 2236608
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
    Pham SM; Kormos RL; Kawai A; Murali S; Hattler BG; Demetris AJ; Griffith BP
    Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of acute cardiac homograft rejection without antilymphocyte globulin.
    Kauffman HM; Lepley D; Johnson D; Kuban D
    Laval Med; 1970 Feb; 41(2):260-1. PubMed ID: 4102120
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual origin of intimal cells in cardiac-allograft arteriosclerosis.
    Kennedy LJ; Weissman IL
    N Engl J Med; 1971 Oct; 285(16):884-7. PubMed ID: 4939537
    [No Abstract]   [Full Text] [Related]  

  • 10. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
    Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK
    Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac transplantation in man. II. Immunosuppressive therapy.
    Stinson EB; Dong E; Bieber CP; Popp RL; Shumway NE
    J Thorac Cardiovasc Surg; 1969 Sep; 58(3):326-37. PubMed ID: 4980410
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status of clinical cardiac transplantation.
    Lower RR
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):107-13. PubMed ID: 4280167
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience in transplantation of the human heart: report of ten cases.
    Cooley DA; Nora JJ; Trentin JJ; Hallman GL; Bloodwell RD; Leachman RD
    Transplant Proc; 1969 Jun; 1(2):703-12. PubMed ID: 4939667
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficiency of sheep antidog antilymphocyte serum (SADALS) in the prolongation of canine heart allografts.
    Halpern B; Cachera JP; Lacombe M; Hathaway A; Crepin Y; Hung BM; Lacassagne JP; Leandri J; Laurent D; Dubost C; de Mendoza M
    Transplant Proc; 1969 Mar; 1(1):467-9. PubMed ID: 4944261
    [No Abstract]   [Full Text] [Related]  

  • 16. Antirejection drugs and procedures.
    Chatterjee SN
    Am J Surg; 1973 Nov; 126(5):678-82. PubMed ID: 4129988
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelialitis in accelerated allograft arteriosclerosis in human cardiac transplant recipients.
    Paavonen T; Mennander A; Lautenschlager I; Häyry P
    Transplant Proc; 1992 Feb; 24(1):342-3. PubMed ID: 1539307
    [No Abstract]   [Full Text] [Related]  

  • 18. Will atherosclerosis limit clinical xenografting?
    Reemtsma K; Pierson RN; Marboe CC; Michler RE; Smith CR; Rose EA; Fenoglio JJ
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):108-18. PubMed ID: 3303561
    [No Abstract]   [Full Text] [Related]  

  • 19. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B
    Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.